,28 For example, disruptor of telomeric silencing 1-like (DOT1L) promotes tumor progression in gliomas by mediating histone H3K79 methylation (H3K79me), which activates the stemness markers including NANOG and SOX2.29 Here, DOT1L is linked to neoplasm.